Ethris has partnered Lonza for the development of room-temperature stable mRNA vaccine candidates targeting respiratory ...

The FDA has granted clearance to CureVac's IND for the open-label Phase I trial of CVHNLC in individuals with sqNSCLC.

A team of researchers led by Dr. KIM V. Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that affects the function of ...

Primrose Bio announced a new product to improve the manufacturing on long-template mRNA vaccines. 1 The Prima RNApols ExTend ...

The FDA has granted approval for the IND application of Everest Medicines’ tumour-associated antigen (TAA) vaccine, EVM14.

Fintel reports that on March 20, 2025, Wolfe Research initiated coverage of InvenTrust Properties (NYSE:IVT) with a Peer Perform recommendation. As of March 19, 2025, the average one-year price ...

AI-generated image of cancer being attacked by an mRNA vaccine. In the midst of the COVID-19 pandemic, scientists raced to develop vaccines in record time. The first reliable vaccines, using ...

Hyundai’s hydrogen fuel-cell prototype is now market-ready and will be fully demonstrated at Bauma Munich, setting it up to become a standard-bearer for a trend right across the construction vehicle ...

The mRNA Vaccines Market grew from USD 9.32 billion in 2024 to USD 10.40 billion in 2025. It is expected to continue growing at a CAGR of 11.86%, reaching USD 18.28 billion by 2030.

Get Instant Summarized Text (Gist) The NIH has reportedly advised scientists to omit mRNA vaccine references from grant applications, suggesting a potential shift away from this research area ...

Officials at the National Institutes of Health (NIH) have reportedly told scientists to scrub all references to mRNA vaccine technology from grant applications, sparking fears that the agency ...